Hyperglucagonemia increases resting metabolic rate in man during insulin deficiency
The DOI matches its Crossref record.
Abstract
The physiological significance of the hyperglucagonemia that occurs in patients with many catabolic conditions is unclear. The effect of hyperglucagonemia on resting metabolic rate (RMR) was studied in six normal subjects. Infusion of somatostatin (SRIH; 500 micrograms/h for 210 min) resulted in a 5-fold decrease in plasma C-peptide and a 2-fold decrease in plasma insulin and glucagon concentrations, but did not change RMR significantly. When glucagon (0.2 micrograms/kg X h), was infused with SRIH (500 micrograms/h for 210 min), the decreases in plasma C-peptide and insulin were similar to that during the infusion of SRIH alone, but plasma glucagon increased from 160 +/- 24 (+/- SEM) to 560 +/- 80 pg/mL (P less than 0.001). There was a significant increase in RMR during the entire period (210 min) of glucagon infusion (P less than 0.01). During the last hour of the glucagon plus SRIH infusion, the RMR was 1.38 +/- 0.10 Cal/min, which was 15% higher than the preinfusion RMR (1.19 +/- 0.10 Cal/min; P less than 0.01) and 14% higher than the RMR during the same period when SRIH alone was infused (1.21 +/- 0.11 Cal/min; P less than 0.01). When SRIH and glucagon were infused, protein oxidation (calculated from urinary nitrogen loss) was 52 +/- 5 mg/min, 29% higher than when SRIH alone was infused (40 +/- 5 mg/min; P less than 0.05). These results indicate that hyperglucagonemia during insulin deficiency results in an increase in energy expenditure, which may contribute to the catabolic state in many conditions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Besides, small-scale studies support the ability of glucagon receptor activation to increase metabolic rate in both fed and fasted conditions, making the glucagoneglucagon receptor axis an attractive therapeutic approach to combine with anti-obesity medications that work by reducing caloric intake (Nair, 1987;Tan et al, 2013;Salem et al, 2016;Stahel et al, 2019).”
From Emerging pharmacotherapies for obesity: A systematic review (2025) · cites this paper as Nair, 1987
In the citing paper
“Moreover, glucagon, whose effects on blood glucose counteract insulin's, has a thermogenic effect (50).”
From Altered mitochondrial function in insulin-deficient and insulin-resistant states (2018) · cites this paper as [50]
Citations
Cites
Still being checked.
Cited by
Physiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease
Sandoval, D. A., & D'Alessio, D. A. (2015) · Physiological Reviews · doi:10.1152/physrev.00013.2014 · Cited by 498
The New Biology and Pharmacology of Glucagon
Müller, T. D., Finan, B., Clemmensen, C., DiMarchi, R. D., & Tschöp, M. H. (2017) · Physiological Reviews · doi:10.1152/physrev.00025.2016 · Cited by 419
“Notably, while several studies support that glucagon also affects energy expenditure in humans (89, 449), the contribution of the brown adipose tissue in mediating these effects in humans remains to be determined.”
BackgroundThe metabolic actions of glucagon revisited
Habegger, K. M., Heppner, K. M., Geary, N., Bartness, T. J., DiMarchi, R., & Tschöp, M. H. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.187 · Cited by 406
The Glucagonoma Syndrome Clinical and Pathologic Features in 21 Patients
Wermers, R. A., Fatourechi, V., Wynne, A. G., Kvols, L. K., & Lloyd, R. V. (1996) · Medicine · doi:10.1097/00005792-199603000-00002 · Cited by 322
Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease.
Baggio, L. L., & Drucker, D. J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101090 · Cited by 299
Metadata
- Authors
- NAIR, K. S.
- Affiliations
- University of Rochester Medicine (US)
- Corresponding author
- NAIR, K. SREEKUMARAN
- ORCID
- NAIR, K. SREEKUMARAN
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1987-05
- Volume
- 64
- Issue
- 5
- Pages
- 896-901
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2085655607
- Cited by
- 141
- References
- 0
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 9 · 2023: 10 · 2022: 12 · 2021: 6 · 2020: 5 · 2019: 15 · 2018: 11 · 2017: 3 · 2016: 6 · 2015: 2 · 2014: 3 · 2013: 10 · 2012: 3
- FWCI
- 3.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (AM-20494)
- National Center for Research Resources (RR-00044, RR05403)
- NIH Clinical Center
- Rocky Mountain Research Station
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- hyperglucagonemia, resting metabolic rate, insulin deficiency, somatostatin, glucagon infusion, C-peptide, protein oxidation, energy expenditure, catabolic state, urinary nitrogen loss
- MeSH terms
- Adult, Basal Metabolism, Blood Glucose, C-Peptide, Energy Metabolism, Female, Glucagon, Humans, Insulin, Kinetics, Male, Oxygen Consumption, Somatostatin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hyperglucagonemia increases resting metabolic rate in man during insulin deficiency. https://app.cochat.ai/papers/10.1210/jcem-64-5-896
- The paper
- NAIR, K. S. (1987). Hyperglucagonemia increases resting metabolic rate in man during insulin deficiency. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem-64-5-896
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.